Figure 4.
Figure 4. Subcellular localization of CD44-GFP and CD133-GFP fusion proteins in transfected CD34+ cells. Using the new Amaxa nucleofection technology, human CD34+ cells enriched from umbilical cord blood were transfected with the expression plasmid encoding either for YFP (Ci), CD44-GFP (Di-ii) or CD133-GFP (Ei-ii) under the control of the cytomegalovirus promoter. Transfected cells and, as negative control, untransfected cells (B) were cultivated for 1 day in serum-containing medium supplemented with early acting cytokines and were analyzed by flow cytometry (A-B,Cii,Dii,Eii) and fluorescence microscopy (Ci,Di,Ei). (A-B,Cii,Dii,Eii) A representative experiment (n = 5) of the CB-derived cells untransfected (B) or transfected with different expression plasmids (Cii,Dii,Eii) was stained with a PE-conjugated anti-CD34 antibody and analyzed by flow cytometry. The cells analyzed in panels B, Cii, Dii, and Eii were gated according to the morphology depicted on a forward scatter/side scatter plot (A). Note, cells shown in panel Cii are extremely positive for YFP; most of them stick to the right border of the plot. (Ci,Di,Ei). Differential interference contrast image shows fluorescence overlay of YFP (Ci), CD44-GFP (Di), or CD133-GFP (Ei) in living transfected CD34+-enriched cells. The YFP is strongly expressed throughout the cytoplasm of the cells, whereas CD44-GFP and CD133-GFP are concentrated in the uropod of the migrating cells (arrows in Di and Ei). The white arrows indicate the cells shown in the insets (high magnification).

Subcellular localization of CD44-GFP and CD133-GFP fusion proteins in transfected CD34+ cells. Using the new Amaxa nucleofection technology, human CD34+ cells enriched from umbilical cord blood were transfected with the expression plasmid encoding either for YFP (Ci), CD44-GFP (Di-ii) or CD133-GFP (Ei-ii) under the control of the cytomegalovirus promoter. Transfected cells and, as negative control, untransfected cells (B) were cultivated for 1 day in serum-containing medium supplemented with early acting cytokines and were analyzed by flow cytometry (A-B,Cii,Dii,Eii) and fluorescence microscopy (Ci,Di,Ei). (A-B,Cii,Dii,Eii) A representative experiment (n = 5) of the CB-derived cells untransfected (B) or transfected with different expression plasmids (Cii,Dii,Eii) was stained with a PE-conjugated anti-CD34 antibody and analyzed by flow cytometry. The cells analyzed in panels B, Cii, Dii, and Eii were gated according to the morphology depicted on a forward scatter/side scatter plot (A). Note, cells shown in panel Cii are extremely positive for YFP; most of them stick to the right border of the plot. (Ci,Di,Ei). Differential interference contrast image shows fluorescence overlay of YFP (Ci), CD44-GFP (Di), or CD133-GFP (Ei) in living transfected CD34+-enriched cells. The YFP is strongly expressed throughout the cytoplasm of the cells, whereas CD44-GFP and CD133-GFP are concentrated in the uropod of the migrating cells (arrows in Di and Ei). The white arrows indicate the cells shown in the insets (high magnification).

Close Modal

or Create an Account

Close Modal
Close Modal